Table 2.
Treatment characteristics
| Characteristics (N=62) | n (%) | |
|---|---|---|
| Chemotherapy before hRT |
|
|
| No |
|
29 (47) |
| Yes |
|
33 (53) |
| Time last ChT to hRT (months) |
|
|
| Median (range) |
3 (0.2-43) |
|
| Chemotherapy during hRT |
|
|
| No |
|
60 (97) |
| Yes |
|
2 (3) |
| Other RT prior hRT* |
|
|
| No |
|
54 (87) |
| Yes |
|
8 (13) |
| Time last RT to hRT (months) |
|
|
| Median (range) |
32 (2–128) |
|
| Other hemostatic measure |
|
|
| No |
|
49 (79) |
| Yes |
|
13 (21) |
| Total hRT dose (Gy) |
|
|
| Median (range) |
20 (5–45) |
|
| Region treated by hRT |
|
|
| Uterovaginal |
|
19 (31) |
| Bladder |
|
17 (27) |
| Lung |
|
10 (16) |
| Upper GI |
|
10 (16) |
| Other# |
|
6 (10) |
| Treatment time hRT (days) |
|
|
| Median (range) | 8 (1–25) |
Abbreviations: RT=radiotherapy; hRT=hemostatic radiotherapy; ChT=chemotherapy; GI=gastrointestinal; *in the same region as hemostatic RT; #including lower gastrointestinal (n=4), skin (n=1) and abdominal wall (n=1).